Related Experiment Video
Updated: Aug 18, 2026
MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
Evaluation of human chorionic gonadotropin-beta levels in prostatic carcinoma
Abstract:
Sera of patients with prostatic malignancy were assayed for human chorionic gonadotropin-beta (HCG-beta). The levels of HCB-beta are negligible in the patients and in a control group with benign prostatic hypertrophy. Slight increases in HCG-beta found in a small percentage of patients with advanced malignancy are attributed to cross-reacting gonadotropins.
More Related Videos
13:19Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 3, 2013
07:34Enhancing Prostate Tumor Biobanking Reliability with Improved Sampling Technique and Histological Characterization
Published on: November 17, 2023